Summary: Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed)
Publications227 found, 100 shown here
- Risk-sharing: past, present, futureDean C Coddington
Healthc Leadersh Manag Rep 11:1-7, 9. 2003
- Prescription drug cost sharing: associations with medication and medical utilization and spending and healthDana P Goldman
Health Economics, Finance, and Organization, RAND, Santa Monica, California 90407 2138, USA
JAMA 298:61-9. 2007Prescription drugs are instrumental to managing and preventing chronic disease. Recent changes in US prescription drug cost sharing could affect access to them.
- Effects of increased patient cost sharing on socioeconomic disparities in health careMichael Chernew
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
J Gen Intern Med 23:1131-6. 2008Increasing patient cost sharing is a commonly employed mechanism to contain health care expenditures.
- Effects of cost sharing on care seeking and health status: results from the Medical Outcomes StudyM D Wong
Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, USA
Am J Public Health 91:1889-94. 2001This study sought to determine the effect of cost sharing on medical care use for acute symptoms and on health status among chronically ill adults.
- Coping with prescription drug cost sharing: knowledge, adherence, and financial burdenMary Reed
Division of Research, Kaiser Permanente Medical Care Program, 2000 Broadway, Oakland, CA 94612, USA
Health Serv Res 43:785-97. 2008Assess patient knowledge of and response to drug cost sharing.
- Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockersSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02120, USA
Clin Pharmacol Ther 74:388-400. 2003....
- Physician gender and changes in drug prescribing after the implementation of reference pricing in British ColumbiaMargreet S Duetz
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Clin Ther 25:273-84. 2003..However, these differences are unlikely to have meaningful clinical or economic consequences...
- The impact of cost sharing on antidepressant use among older adults in British ColumbiaPhilip S Wang
National Institute of Mental Health, Bethesda, MD 20892 9629, USA
Psychiatr Serv 59:377-83. 2008....
- Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessmentPaul Grootendorst
McMaster University and Centre for Evaluation of Medicines, Hamilton, Ontario, Canada
Can J Clin Pharmacol 9:79-99. 2002..Each province has, however, provided coverage to senior citizens and social assistance recipients; some provinces have introduced drug coverage for the general public...
- Preferences for patient cost sharing among medicare beneficiaries after HMO plan withdrawalsAudiey C Kao
Received from the Institute for Ethics, American Medical Association, Chicago, Ill 60610, USA
J Gen Intern Med 17:446-50. 2002..To assess Medicare beneficiaries' willingness to cost share in order to minimize disruptions in coverage from HMO plan withdrawals...
- Outcomes of reference pricing for angiotensin-converting-enzyme inhibitorsSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 346:822-9. 2002..Although reference pricing may reduce the costs of prescription drugs, there is concern that patients may switch to less effective medications or stop treatment...
- Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demandC van de Voorde
Department of Economics, University of Leuven, Belgium
Health Econ 10:457-71. 2001The effects of cost sharing on the demand for ambulatory care in experimental circumstances are well understood since the Rand Health Insurance Experiment (HIE)...
- Rising out-of-pocket costs in disease management programsMichael E Chernew
University of Michigan, Ann Arbor, MI 48109 2029, USA
Am J Manag Care 12:150-4. 2006..To document the rise in copayments for patients in disease management programs and to call attention to the inherent conflicts that exist between these 2 approaches to benefit design...
- Dramatic improvement or death spiral--two members of congress assess the Medicare billEdward M Kennedy
N Engl J Med 350:747-51. 2004
- Effect of cost sharing on screening mammography in Medicare health plansAmal N Trivedi
Department of Community Health, Warren Alpert Medical School of Brown University, Providence, RI 02912, USA
N Engl J Med 358:375-83. 2008..Policies that increase patients' share of health care expenses decrease the use of discretionary health services but also may reduce the use of important preventive care such as mammography...
- Patient cost sharing and social inequalities in access to health care in three western European countriesLourdes Lostao
Department of Sociology, Sociology of Health, Universidad Publica de Navarra, Spain
Soc Sci Med 65:367-76. 2007..hospitalization, in Germany they share the cost of hospitalization, and in Spain there is no system of patient cost sharing. The data were obtained from national health surveys carried out in each of these countries during the last ..
- Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider settingJared T Lurk
Department of Pharmacy, Saint Luke's Hospital of Kansas City, Kansas City, MO, USA
Am J Health Syst Pharm 61:267-72. 2004..Removal of prescription drug samples had no effect except increasing patients' out-of-pocket drug costs...
- An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetesRonald T Ackermann
Department of Medicine, Indiana University School of Medicine, 250 University Blvd, Suite 122, Indianapolis, IN 46202, USA
Diabetes Care 29:1237-41. 2006..We explored whether this intervention could be offered in a way that allows return on investment for private health insurers while remaining attractive for consumers, employers, and Medicare...
- Value-based insurance designMichael E Chernew
Harvard University, Boston, Massachusetts, USA
Health Aff (Millwood) 26:w195-203. 2007..This paper makes the case for VBID and outlines current VBID initiatives in the private sector as well as barriers to further adoption...
- Discontinuation of cost sharing in UgandaGilbert M Burnham
Department of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Bull World Health Organ 82:187-95. 2004To assess the effects of ending cost sharing on use of outpatient services and how this was perceived by health workers and members of a health unit management committee.
- Exemptions and waivers from cost sharing: ineffective safety nets in decentralized districts in UgandaGeorge W Kivumbi
Makerere University Medical School, Child Health and Development Centre, Parliament of the Republic of Uganda, Kampala, Uganda
Health Policy Plan 17:64-71. 2002..The implications of the findings for remedying the tension between the needs for cost recovery and for attainment of equity goals through exemption policies for the poor and indigent are discussed...
- Linking cost sharing to value: an unrivaled yet unrealized public health opportunityR Scott Braithwaite
Yale University School of Medicine and Veterans Affairs Connecticut Healthcare System, New Haven, Connecticut 06516, USA
Ann Intern Med 146:602-5. 2007As the financial burden of cost sharing continues to rise, patients increasingly avoid necessary care, thereby contributing to the high morbidity and mortality of the U.S. population compared with that of other developed countries...
- Patient cost sharing and physician visits by socioeconomic position: findings in three Western European countriesLourdes Lostao
Department of Sociology, Universidad Publica de Navarra, Campus de Arrosadia, 31006 Pamplona Navarra, Spain
J Epidemiol Community Health 61:416-20. 2007..the probability of physician visits in three Western European countries, one of which has a system of patient cost sharing was evaluated. Cross-sectional surveys were performed in France, Germany and Spain around 1990 and around 2000...
- Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experimentSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
Circulation 115:2128-35. 2007....
- The effects of prescription drug cost sharing: a review of the evidenceTeresa B Gibson
Medstat, 777 E Eisenhower Parkway, Ann Arbor, MI 48108, USA
Am J Manag Care 11:730-40. 2005To determine whether patients respond to increased cost sharing by substituting less expensive alternatives for medications with higher levels of copayments or coinsurance, and to examine the body of evidence on the relationships between ..
- The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniorsThomas Rice
University of California at Los Angeles, Los Angeles, CA, USA
Med Care Res Rev 61:415-52. 2004This article provides a review of research that has addressed the impact of patient cost sharing on the use of services and resulting health status impacts, among the population age 65 and older...
- Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costsA Mark Fendrick
Am J Manag Care 12:18-20. 2006
- The effects of patient cost sharing on ambulatory utilization in South KoreaJiyun Kim
Department of Health Policy and Management, School of Public Health, Seoul National University, 28 Yunkun-Dong, Chongro-Ku, Seoul 110-799, South Korea
Health Policy 72:293-300. 2005This study focused mainly on the effects of patient cost sharing on the demand for physician service, especially in the low-income people...
- Adverse events associated with prescription drug cost-sharing among poor and elderly personsR Tamblyn
McGill University Health Center, Royal Victoria Hospital Site, Ross Pavilion, Room 4-12, 687 Pine Ave W, , Quebec, Canada H3A 1A1
JAMA 285:421-9. 2001....
- A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition costA M Fendrick
Division of General Internal Medicine, Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI, USA
Am J Manag Care 7:861-7. 2001..on monitoring clinical conditions, drug use, and compliance, whereas other efforts have focused on consumer cost sharing and changing product-mix...
- Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistanceLucie Blais
Faculte de Pharmacie, Centre de Recherche, Hôtel Dieu du Centre hospitalier de l Université de Montréal CHUM, C P 6128, Succursale Centre Ville, Quebec, H3C 3J7, Montreal, Canada
Health Policy 64:163-72. 2003..A cost-sharing drug insurance plan has been implemented among people receiving social assistance who had previously free access to medications...
- Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening servicesSu Ying Liang
University of California, 3333 California St, Suite 420, Box 0613, San Francisco, CA 94143, USA
Am J Manag Care 10:99-107. 2004To examine whether there are differential impacts of patient cost sharing and health plan organizational characteristics on the use of a recommended cancer screening service (mammography) versus a controversial cancer screening service (..
- Will reference pricing address the health cost conundrum?John K Iglehart
Health Aff (Millwood) 22:7-8. 2003
- Escalating need for comparative analysis of drugs within a therapeutic classDiane Giaquinta
Manag Care Interface 16:32-4. 2003
- The arrival of consumer-centric healthcareAmit K Gupta
CareGain, Monroe Township, NJ, USA
Manag Care Q 11:20-3. 2003..Making consumers active participants in the next generation of health plans is a necessity. Making it happen, however, will be a challenge...
- Reference pricing for drugs: is it compatible with U.S. health care?Panos Kanavos
Harvard Medical School, USA
Health Aff (Millwood) 22:16-30. 2003..drugs, health insurance systems abroad have experimented in recent years with a novel form of patient cost sharing called "reference pricing...
- Should we be worried about high real medical spending growth in the United States?Mark V Pauly
Department of Health Care Systems, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) . 2003..Problems are more severe for public-sector spending, for the uninsured, and for those responding to distorted incentives...
- Defined contribution: a part of our futureReginald F Baugh
3 Parklane Boulevard, Suite 1212 West, Dearborn, MI 48126, USA
J Natl Med Assoc 95:718-21. 2003..Possible outcomes of widespread adoption of defined contribution plans are presented...
- Consumer choice and tiered networks--two sides of the same coin?Allan Baumgarten
Manag Care Q 11:54-5. 2003
- Member satisfaction related to self-reported cost share and difficulty in obtaining prescription drugs in a university pharmacy benefit planDavid P Nau
University of Kentucky, 725 Rose St, Lexington, KY 40536 0082, USA
J Manag Care Pharm 13:135-41. 2007....
- Pharmaceutical formularies: the right formula for cost and utilization?Bonnie Austin
Changes in Health Care Financing and Organization HCFO, USA
Find Brief 7:1-3. 2004
- Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patientsChien Wen Tseng
Department of Family Practice and Community Health, University of Hawaii, and Pacific Health Research Institute, Honolulu, USA
JAMA 290:222-7. 2003..Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit...
- This isn't the first attempt to shift cost to employeesMartin Sipkoff
Manag Care 12:34-8. 2003
- Looking at the doughnut hole in health insuranceIsaac Sorkin
Health Aff (Millwood) 24:1184-5; author reply 1185. 2005
- Making health care more accessible and affordableMegan Hauck
Hosp Outlook 7:9-10. 2004
- Consumer-directed health care: are consumers ready?Patrick J Dunne
Respir Care 49:1305-6. 2004
- The role of the safety net in employer health benefit decisionsM Susan Marquis
Med Care Res Rev 62:435-57. 2005..Policies to limit crowd-out should focus on incentives to make continued private insurance purchase attractive to workers rather than incentives to employers...
- Medicare prescription drug discount cardsNatasha Bryant
Institute for the Future of Aging Services, USA
Issue Brief Cent Medicare Educ 5:1-6. 2004..In this brief, we discuss the Medicare-approved discount cards--who is eligible, how they work, how your clients can best make important decisions about them, and what help is out there for people with low incomes...
- The cost of admission--tiered copayments for hospital useRobert Steinbrook
N Engl J Med 350:2539-42. 2004
- Pharmacy benefits and the use of drugs by the chronically illDana P Goldman
RAND, Santa Monica, Calif 90407 2138, USA
JAMA 291:2344-50. 2004Many health plans have instituted more cost sharing to discourage use of more expensive pharmaceuticals and to reduce drug spending.
- Consumer-driven health care: the future is nowRonald E Bachman
Benefits Q 20:15-22. 2004..This article reviews the factors leading to the need for consumer-driven health care and describes the characteristics and benefits of its current and next generations of development...
- Balancing quality employee benefits with cost sharingWayne M Lenda
Eastman Kodak Company, Rochester, NY 14650, USA
Am J Manag Care 12:S165-6; discussion S167-72; quiz S173-6. 2006
- The evolving role of case management in consumer-centric health plansJeff Frater
Redding Medical Center, California, USA
Case Manager 15:61-5. 2004
- The costs of mental health parity: still an impediment?Colleen L Barry
Division of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
Health Aff (Millwood) 25:623-34. 2006..We review both eras of research on mental health insurance and conclude that comprehensive parity implemented in the context of managed care would have little impact on total spending...
- The effects of expanded mental health benefits on treatment costsAnthony T Lo Sasso
Division of Health Policy and Administration, School of Public Health, University of Illinois at Chicago, 1603 W Taylor, Chicago IL 60660, USA
J Ment Health Policy Econ 9:25-33. 2006..This study examines the impact that corporate benefit policies can have on mental health treatment costs...
- The plan: drive consumers onlineZack Martin
Health Data Manag 14:40, 42, 44 passim. 2006
- The effect of incentive-based formularies on prescription-drug utilization and spendingHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 349:2224-32. 2003..Many employers and health plans have adopted incentive-based formularies in an attempt to control prescription-drug costs...
- Incentive-based formulariesCindy Parks Thomas
Heller School for Social Policy and Management, Brandeis University, Waltham, Mass, USA
N Engl J Med 349:2186-8. 2003
- Easing the pain. Slowing prescription drug expense helps rein in costs for large employersJessica Zigmond
Mod Healthc 36:30. 2006
- Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disordersJack M Rosenberg
International Drug Information Center, Brooklyn, NY 11201, USA
Am J Health Syst Pharm 64:S18-23; quiz S24-5. 2007..Medicare Part D prescription drug benefits are reviewed. Potential implications for patients with psychotic disorders in relation to Medicare Part D are discussed...
- Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnessesJulie M Donohue
Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, Pennsylvania 15261, USA
Psychiatr Serv 56:645-7. 2005
- Managing prescription drug costsJ M Sica
Aon Consulting, Conshohocken, Pennsylvania, USA
Empl Benefits J 26:35-40. 2001..The author also discusses pharmacy benefit managers, as well as various utilization management strategies like benefit plan design and the use of formularies...
- The state of consumer-centric careClive Riddle
MCOL, Modesto, California, USA
Manag Care Interface 15:20-4. 2002..Health plans are today faced with the challenge of rethinking their offerings--or even their basic program approach--to address this burgeoning trend...
- Insurance product design and its effects: trade-offs along the managed care continuumPeter Kemper
Department of Health Policy and Administration, Pennsylvania State University, University Park 16802 6500, USA
Inquiry 39:101-17. 2002....
- Employer drug benefit plans and spending on prescription drugsGeoffrey F Joyce
RAND Health, 1700 Main St, Santa Monica, CA 90407 2138, USA
JAMA 288:1733-9. 2002..It is unknown how these initiatives affect drug costs...
- Changing health insurance trendsJohn K Iglehart
N Engl J Med 347:956-62. 2002
- Responding to consumer demand for choice, flexibilityMary Brainerd
Healthplan 43:13-7. 2002
- Pharmacy discount card programs: catching up with the health marketsDrew Edwards
Kenco Insurance Agency, Louisville, Kentucky, USA
Empl Benefits J 27:42-3. 2002..Pharmacy costs continue to rise, as does the number of senior citizens. One of the ways of containing costs may be the pharmacy discount drug card program, for both seniors and the general population...
- Towers Perrin's outlook: what employers (and providers) need to know about defined contribution health plansMichael Taylor
Manag Care Q 10:9-12. 2002....
- Optimizing growth opportunities during the managed care revolutionBill DeMarco
DeMarco and Associates, Rockford, Illinois, USA
Healthc Financ Manage 56:42-6. 2002....
- Controlling spending for prescription drugsStuart H Altman
N Engl J Med 346:855-6. 2002
- Employee demand for health insurance and employer health plan choicesM Kate Bundorf
Department of Health Medicine, Stanford University School of Medicine, CA 94305 5405, USA
J Health Econ 21:65-88. 2002..Although the results suggest that employers do respond to employee preferences in choosing health benefits, the effects of worker characteristics on plan offerings are quantitatively small...
- Controlling prescription drug expenditures: a report of successDavid P Miller
General Internal Medicine, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA
Am J Manag Care 13:473-80. 2007..To determine whether a multi-interventional program can limit increases in prescription drug expenditures while maintaining utilization of needed medications...
- Spousal surcharge programs--an overviewHudson A Peters
Mercer Human Resource Consulting, Cincinnati, Ohio, USA
Benefits Q 21:19-25. 2005..This article explores the prevalence, plan design, financial implications, administrative and other considerations in implementing a spousal surcharge program...
- Living with GASB 45: how to manage liabilities associated with retiree medical benefitsFrank Thoen
Milliman, Inc, Seattle, USA
Benefits Q 24:39-45. 2008..Now is the time for employees and employers to work together and make difficult choices for keeping retiree medical costs and GASB 45 liabilities manageable...
- Financial consequences of drug benefit plansBartholomew E Clark
JAMA 289:423; author reply 424. 2003
- Financial consequences of drug benefit plansJohn Hsu
JAMA 289:423; author reply 424. 2003
- Impact of health plan design and management on retirees' prescription drug use and spending, 2001Cindy Parks Thomas
Schneider Institute for Health Policy, Brandeis University, Waltham, Massachusetts, USA
Health Aff (Millwood) . 2002..cost-sharing requirements combined with other management strategies were associated with greater member cost sharing, a shift to less costly medications (generic and mail order), and lower total prescription drug spending...
- Will employee choice and defined contribution health plans salvage the embattled managed care system?Peter M Kelly
Benefits Q 19:32-50. 2003....
- Adverse selection and generosity of alcohol treatment benefitsKatherine M Harris
Division of Clinical and Prevention Research, National Institute on Alcohol Abuse and Alcoholism (NIAAA, Rockville, MD 20852, USA
Inquiry 39:413-28. 2002..Also, users of alcohol treatment services do not remain disproportionately enrolled longer in plans with generous benefits...
- Approaches to pharmacy benefit management and the impact of consumer cost sharingBridget M Olson
The University of Arizona, College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, Tucson, Arizona 85721-0207, USA
Clin Ther 25:250-72. 2003..and equitably deliver pharmacy benefits and to discuss the impact of such programs, including consumer cost sharing. METHODS: A review of the literature was conducted using the PreMedline and MEDLINE databases from the years ..
- How long can employers hang on?Shelly Reese
Bus Health 20:5-9. 2002
- [Evaluation of accessibility to drugs for patients in the years 1996-2001]Mariola Drozd
Zakładu Zarzqdzania i Ekonomiki Farmaceutycznej Akademii Medycznej w Lublinie
Wiad Lek 55:651-4. 2002..In consequence of these effects it was the diminution of the accessibility to the drugs by the patients on account of a growth of patient participation in the pharmacotherapy costs...
- Medicare prescription drug plan costs and affordability--2007Matthew M Davis
J Gen Intern Med 22:1221-2. 2007
- Integrating new technology without going brokeCynthia Starr
Bus Health 20:29-34. 2002
- Why incremental reforms will not solve the health care crisisDon McCanne
Physicians for a National Health Program, Chicago, Ill, USA
J Am Board Fam Pract 16:257-61. 2003
- Financial consequences of drug benefit plansBrenda Motheral
JAMA 289:423-4; author reply 424. 2003
- Differences in the cost of antidepressants across state Medicaid programsChristina M L Kelton
College of Business, University of Cincinnati, PO Box 210223, Cincinnati, OH 45221 0223, USA
J Ment Health Policy Econ 11:33-47. 2008....
- Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroidsBrian L Meissner
College of Pharmacy, Department of Pharmaceutical and Health Outcomes Sciences, University of South Carolina, 1425 Richland St, Columbia, SC 29201, USA
J Manag Care Pharm 10:226-33. 2004Health plans are using 3-tier copayment designs and other methods to control utilization that shifts drug costs to plan members. There is a need to determine the effects of increased member cost sharing on drug utilization and drug costs.
- United Kingdom (England): Health system reviewSean Boyle
LSE Health and Social Care, London School of Economics and Political Science
Health Syst Transit 13:1-483, xix-xx. 2011..Some care is funded privately through PMI, some user charges, cost sharing and direct payments for health care delivered by NHS and private providers...
- Spending on medicines in Israel in an international contextPhilip Sax
Center for Drug Studies, and PHARMA Israel Drug Bulletin, Jerusalem, Israel
Isr Med Assoc J 7:286-91. 2005..Like most developed countries, in the last decade Israel's healthcare system has been subject to cost-containing measures in the drug sector...
- Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countriesS Ratanawijitrasin
Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
Soc Sci Med 53:831-44. 2001..Interrupted time-series analysis and other more rigorous designs should become standard designs for policy evaluation in the same way that standard treatment guidelines are intended to guide medical practice...
- Insurance coverage and the treatment of mental illness: effect on medication and provider useGillian Mulvale
Mental Health Commission of Canada, 1145 Carling Ave, Suite 7500, Ottawa, Ontario, Canada K1Z 74A
J Ment Health Policy Econ 11:177-99. 2008..3%) receive drug treatment. Financial barriers to care constitute a potentially important contributor to this under-use of mental health treatments...
- Medicare Part D: selected issues for pharmacists and beneficiaries in 2007Janet Kilian
Amabulatory Care Pharmacy Department, University of Illinois at Chicago College of Pharmacy, 833 South Wood St, MC 886, Chicago, IL 60612, USA
J Manag Care Pharm 13:59-65. 2007..Pharmacists will continue to be an essential and integral part of the continued success of the Medicare prescription drug benefit in 2007, in part by being informed about the policies and regulations...
- Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefitJoel V Brill
Predictive Health, LLC, Phoenix, AZ 85016, USA
Am J Health Syst Pharm 64:S3-6; quiz S21-S23. 2007....
- Drug benefit decisions among older adults: a policy-capturing analysisRichard R Cline
College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
Med Decis Making 26:273-81. 2006....
- Trends in mental health insurance benefits and out-of-pocket spendingDavid R McKusick
The MEDSTAT Group, 4301 Connecticut Avenue, NW Suite 330, Washington, DC 20008, USA
J Ment Health Policy Econ 5:71-8. 2002..Insurance benefits can have a large effect on whether one is able to access health care services. Mental health and substance abuse (MHSA) insurance coverage has typically been less generous than that of general health services...
- Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999Jennifer A Palmer
Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, 800 Washington Street, 063, Boston, MA 02111, USA jpalmer tuftsmedicalcenter org
J Manag Care Pharm 14:749-55. 2008..We previously investigated the promotional claims made by pharmaceutical companies about the economic advantages of their prescription products in print advertisements in 6 leading medical journals from 1990-1999...
- Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart diseaseA D Federman
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
JAMA 286:1732-9. 2001..001). CONCLUSION: Elderly Medicare beneficiaries with CHD who lack drug coverage have disproportionately large drug expenditures and lower use rates of statins, a class of relatively expensive drugs that improve survival...
- Are incentive-based formularies inversely associated with drug utilization in managed care?Patrick P Gleason
Prime Therapeutics, LLC, Eagan, MN 55121 3497, USA
Ann Pharmacother 39:339-45. 2005..To review recent studies comprehensively assessing the impact of incentive-based multitier formularies on pharmaceutical costs and utilization...
- Taiwan's 1995 health care reformT L Chiang
Institute of Public Health and Center for Health Policy Research, National Taiwan University, Taipei
Health Policy 39:225-39. 1997..new scheme is financed mainly by payroll tax and provides comprehensive health care benefits with a moderate cost sharing. In order to gain efficiency in delivering health services, the scheme enters contracts with health care ..
- Medicare Drug Benefits and High Cost Medications: Antipsychotics Under Part DVicki Fung; Fiscal Year: 2011....
- CONSEQUENCES OF DRUG COST SHARING IN THE ELDERLYSebastian Schneeweiss; Fiscal Year: 2002..Additional analyses will examine possible changes in prescribing patterns for persons initiating ACEI or CCB treatment. ..
- Improved Targeting and Assessment of Electrophysiology InterventionHenry R Halperin; Fiscal Year: 2010..Hopkins University Departments of Medicine, Radiology, and Biomedical Engineering;and industrial partners (with cost sharing): Irvine Biomedical (clinical grade catheters), Hansen Medical (catheter manipulation system), and Imricor (..
- Improved Targeting and Assessment of Electrophysiology InterventionHenry Halperin; Fiscal Year: 2009..University Departments of Medicine, Radiology, and Biomedical Engineering; and industrial partners (with cost sharing): Irvine Biomedical (clinical grade catheters), Hansen Medical (catheter manipulation system), and Imricor (..
- Consequences of Drug Cost Sharing:A New Randomized TrialSebastian Schneeweiss; Fiscal Year: 2006Differential drug cost sharing (DCS), a measure that increases patients' co-payments for more expensive drugs, is increasingly used by U.S. health plans to contain drug costs...
- Choice and Consequences in the Medicare Part D PlanJonathan Gruber; Fiscal Year: 2010..These findings should be very helpful to policy-makers as they consider ongoing reforms of this major entitlement program. ..
- Choice and Consequences in the Medicare Part D PlanJonathan Gruber; Fiscal Year: 2009..These findings should be very helpful to policy-makers as they consider ongoing reforms of this major entitlement program. ..
- Genetic and Environmental Determinants of Type 2 Diabetes in Chinese SingaporeansMark A Pereira; Fiscal Year: 2010..The study has tremendous potential to improve our understanding of type 2 diabetes risk in Southeast Asians, leading to improved prevention efforts. ..
- Genetic and Environmental Determinants of Type 2 Diabetes in Chinese SingaporeansMark Pereira; Fiscal Year: 2009..The study has tremendous potential to improve our understanding of type 2 diabetes risk in Southeast Asians, leading to improved prevention efforts. ..
- Medicare Advantage?Lauren Nicholas; Fiscal Year: 2007..MMC enrollees accept network and utilization restrictions in exchange for additional benefits and reduced cost sharing compared to fee-for-service Medicare (FFS)...
- Int'l Population on Macronutrients and BP - INTERMAPJeremiah Stamler; Fiscal Year: 2007..K., U.S.). Cost effectiveness is assured by cost sharing by London centers and inclusion here of data analysis/reporting aims from 5 on-going NHLBI supported projects...
- Modeling Adherence to Psychotherapy for DepressionGregory Simon; Fiscal Year: 2009..The proposed research is one component of an ongoing comprehensive program to understand and increase consumer demand for effective depression treatment. ..
- Sedative Hypnotic Use by the Mentally Ill: A Medicaid Prescription Policy StudyJudy Zerzan; Fiscal Year: 2009..impact of three sedative hypnotic access restriction policies (preferred drug lists, prior authorization and cost sharing). Each state's analysis cohort is all people with an MI diagnosis...
- Sedative Hypnotic Use by the Mentally Ill: A Medicaid Prescription Policy StudyJUDY T contact ZERZAN; Fiscal Year: 2010..impact of three sedative hypnotic access restriction policies (preferred drug lists, prior authorization and cost sharing). Each state's analysis cohort is all people with an MI diagnosis...
- INTL POPULATION STUDY ON MACRONUTRIENTS AND BP INTERMAPJeremiah Stamler; Fiscal Year: 1999....
- Medicare Study of Cost-sharing Ramifications and Prescription Drug BenefitsJohn Hsu; Fiscal Year: 2009..This study will be the first to examine the clinical and economic effects of new Medicare Part D plans, using comprehensive automated data from before and after the introduction of Part D, for a well- defined population. ..
- Prescription Drug Cost-sharing: Affordability/SafetyJohn Hsu; Fiscal Year: 2005..This study will be the first to address these issues within a broad sample of Medicare beneficiaries. ..
- Impact of Medicare Drug Coverage on Antidepressant Quality and OutcomesSebastian Schneeweiss; Fiscal Year: 2007..g., to formulary, cost-sharing, and MTM programs) be made to improve the quality and outcomes of pharmacotherapies in susceptible and traditionally under-served elderly with depression. ..
- HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOMEBOYD METZGER; Fiscal Year: 2003..Cost effectiveness for the HAPO study is enhanced through cost sharing by colleagues in non-U.S. centers.
- Remibursement Limits, Antidepressants, and OutcomesPhilip Wang; Fiscal Year: 2005..We will also use other national and international forums to inform ongoing debates over drug coverage for vulnerable elderly patients with depression. ..
- INTL POPULATION STUDY ON MACRONUTRIENTS AND BP INTERMAPJeremiah Stamler; Fiscal Year: 2003....